Skip to content

Medical Affairs in the Age of Complexity: From Scientific Support to Strategic Enterprise Integrator

Jul 2026 · Pharmaceutical Medicine · Vol 40, pp. 365 - 371 · 0 citations · 26 references
Medicine

TL;DR

This Leading Article proposes a conceptual but operationally applicable framework that positions Medical Affairs as a Strategic Enterprise Integrator, responsible for coordinating lifecycle evidence architecture, scientific exchange, insight translation, and governance across development and real-world settings.

View source

Similar papers

Open access Aug 2026

Integrated Evidence Generation Planning: Why Medical Affairs is a Critical Partner

This article presents IEGP development as a collaborative and strategic process, which enables pharmaceutical companies to demonstrate the holistic value of a new therapy to a broader range of healthcare decision makers.

Ronaldo Fujii, Masoud Nouri, M. Khan et al. · 1 citation
Review Open access Sep 2026

From algorithmic performance to ethical governance: a deployment-oriented framework for responsible healthcare AI

The proposed Lifecycle-Integrated Healthcare AI Governance Framework (LIHAG), a four-layer deployment-oriented governance model integrating technical robustness, ethical safeguards, regulatory compliance, regulatory compliance, and human oversight as interdependent dimensions of responsible AI deployment is proposed.

Shehu Mohammed, Neha Malhotra, Sourabh Kumar · 0 citations
Review Open access Aug 2026

Governance and Performance Dashboards for Managing Healthcare Analytics and Artificial Intelligence Implementation Projects in Hospital Systems: A Critical Review

A critical review examines the intersection of predictive analytics and artificial intelligence and governance at the intersection of these fields, drawing on peer-reviewed literature identified through structured searching of bibliographic metadata registries and biomedical indexes to 1 June 2026.

O. Adewuyi, Moshood Khairah Olayinka · 0 citations
Open access Aug 2026

Overcoming the opaque side of AI in healthcare: a lifecycle based approach.

This work proposes nine operational measures - covering transparency-oriented risk and change control, traceability, subgroup and independent validation, usability-based explainability, calibrated clinical evaluation, structured labeling, version-controlled updates, and regulated end-of-life data handling - to support...

E. Bianchini, L. Billeci, Noemi Conditi et al. · 0 citations
Review Open access Sep 2026

Healthcare AI risk management: an innovator-informed approach from frameworks to practical worksheets for proportionate regulatory evidence capture

A targeted evidence synthesis and framework mapping exercise drawing on review-level evidence, scientific databases and regulatory sources found that a codesigned worksheet approach can support proportionate evidence capture and iterative risk management while remaining adaptable across use cases and maturity levels.

Tahmina Zebin, Jin-Yang Wu, F. Colecchia et al. · 0 citations
Review Open access Sep 2026

From Regulatory Authorization to Clinical Accountability: A Control Preventability Framework for Healthcare AI

A Control–Preventability Principle is proposed that allocates accountability according to control, foreseeability, preventability, and meaningful oversight capacity across developers, deploying institutions, and clinicians, with accountability following control over preventable risk rather than merely the physical loca...

Tony T. Williams, Amna Jatoi, Sazain Malik et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.